当前位置:首页 - 行情中心 - 沃华医药(002107) - 财务分析 - 现金流量表

沃华医药

(002107)

  

流通市值:41.77亿  总市值:42.19亿
流通股本:5.71亿   总股本:5.77亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金254,343,800.74901,655,983.68689,523,102.51464,617,345.83
  收到其他与经营活动有关的现金2,637,506.0218,412,574.399,035,349.325,809,630.24
  经营活动现金流入小计256,981,306.76920,068,558.07698,558,451.83470,426,976.07
  购买商品、接受劳务支付的现金35,923,956.37144,453,343.17104,260,984.1268,986,792.7
  支付给职工以及为职工支付的现金45,414,042.37164,025,095.58123,980,413.7484,635,690.62
  支付的各项税费28,917,159.49111,891,470.1480,789,964.4555,146,634.99
  支付其他与经营活动有关的现金79,082,777.32371,173,033.18280,825,836.68186,366,426.01
  经营活动现金流出小计189,337,935.55791,542,942.07589,857,198.99395,135,544.32
  经营活动产生的现金流量净额67,643,371.21128,525,616108,701,252.8475,291,431.75
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额-14,653,57214,650,27214,650,272
  处置子公司及其他营业单位收到的现金净额-820,000820,000820,000
  投资活动现金流入的平衡项目-000
  投资活动现金流入小计-15,473,57215,470,27215,470,272
  购建固定资产、无形资产和其他长期资产支付的现金717,575.21864,503.16546,677.53447,942.53
  投资活动现金流出小计717,575.21864,503.16546,677.53447,942.53
  投资活动产生的现金流量净额-717,575.2114,609,068.8414,923,594.4715,022,329.47
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金87,800,601.690,825,15273,185,1523,920,000
  其中:子公司支付给少数股东的股利、利润3,528,00021,560,0003,920,0003,920,000
  支付其他与筹资活动有关的现金101,088.331,147,932.68802,679.4519,985.83
  筹资活动现金流出小计87,901,689.9391,973,084.6873,987,831.44,439,985.83
  筹资活动产生的现金流量净额-87,901,689.93-91,973,084.68-73,987,831.4-4,439,985.83
五、现金及现金等价物净增加额-20,975,893.9351,161,600.1649,637,015.9185,873,775.39
  加:期初现金及现金等价物余额394,037,806.06342,876,205.9342,876,205.9342,876,205.9
  期末现金及现金等价物余额373,061,912.13394,037,806.06392,513,221.81428,749,981.29
补充资料:
  净利润-88,791,071.62-41,177,664.22
  资产减值准备-1,950,661.77-1,545,569.11
  固定资产和投资性房地产折旧-29,205,157.78-14,649,977.89
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-29,205,157.78-14,649,977.89
  无形资产摊销-1,368,526.28-697,544.13
  固定资产报废损失-170,469.99-43,277.14
  财务费用-62,306.1-36,330.2
  投资损失--1,763,146.58--820,176.99
  递延所得税-205,752.52-421,730.96
  其中:递延所得税资产减少-679,115.63-657,056.9
    递延所得税负债增加--473,363.11--235,325.94
  存货的减少-11,720,945.6-4,289,633.59
  经营性应收项目的减少-3,301,923.17--2,144,298.11
  经营性应付项目的增加--4,306,270.2-19,016,219.89
  现金的期末余额-394,037,806.06-428,749,981.29
  减:现金的期初余额-342,876,205.9-342,876,205.9
  现金及现金等价物的净增加额-51,161,600.16-85,873,775.39
公告日期2026-04-082026-01-202025-10-182025-07-22
审计意见(境内)标准无保留意见
TOP↑